Compare OSIS & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSIS | WGS |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 1997 | 2020 |
| Metric | OSIS | WGS |
|---|---|---|
| Price | $201.02 | $63.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $273.29 | $93.50 |
| AVG Volume (30 Days) | 181.0K | ★ 746.0K |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.76 | ★ 62.37 |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $1,089,286,000.00 | $427,539,000.00 |
| Revenue This Year | $6.95 | $12.70 |
| Revenue Next Year | $6.69 | $24.31 |
| P/E Ratio | $132.25 | ★ N/A |
| Revenue Growth | 13.35 | ★ 39.97 |
| 52 Week Low | $186.50 | $32.21 |
| 52 Week High | $311.72 | $170.87 |
| Indicator | OSIS | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 44.05 |
| Support Level | $196.30 | $56.09 |
| Resistance Level | $206.19 | $73.04 |
| Average True Range (ATR) | 5.43 | 5.71 |
| MACD | 1.11 | 0.84 |
| Stochastic Oscillator | 55.33 | 54.92 |
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Geographically, the majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.